Cargando…

Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor

BACKGROUND: Controlling enzyme activity by ligand binding to a regulatory domain of choice may have many applications e.g. as biosensors and as tools in regulating cellular functions. However, until now only a small number of ligand-binding domains have been successfully linked to enzyme activity. G...

Descripción completa

Detalles Bibliográficos
Autores principales: Thor, Doreen, Le Duc, Diana, Strotmann, Rainer, Schöneberg, Torsten
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689208/
https://www.ncbi.nlm.nih.gov/pubmed/19450256
http://dx.doi.org/10.1186/1472-6750-9-46
_version_ 1782167760192667648
author Thor, Doreen
Le Duc, Diana
Strotmann, Rainer
Schöneberg, Torsten
author_facet Thor, Doreen
Le Duc, Diana
Strotmann, Rainer
Schöneberg, Torsten
author_sort Thor, Doreen
collection PubMed
description BACKGROUND: Controlling enzyme activity by ligand binding to a regulatory domain of choice may have many applications e.g. as biosensors and as tools in regulating cellular functions. However, until now only a small number of ligand-binding domains have been successfully linked to enzyme activity. G protein-coupled receptors (GPCR) are capable of recognizing an extraordinary structural variety of extracellular signals including inorganic and organic molecules. Ligand binding to GPCR results in conformational changes involving the transmembrane helices. Here, we assessed whether ligand-induced conformational changes within the GPCR helix bundle can be utilized to control the activity of an integrated enzyme. RESULTS: As a proof of principle, we inserted the luciferase amino acid sequence into the third intracellular loop of the M(3 )muscarinic acetylcholine receptor. This fusion protein retained both receptor and enzyme function. Receptor blockers slightly but significantly reduced enzyme activity. By successive deletion mutagenesis the enzyme activity was optimally coupled to ligand-induced conformational helix movements. CONCLUSION: Our results demonstrate that in engineered GPCR-enzyme chimeras, intracellular enzyme activity can be directly controlled by a GPCR serving as the extracellular ligand-binding domain.
format Text
id pubmed-2689208
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26892082009-06-02 Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor Thor, Doreen Le Duc, Diana Strotmann, Rainer Schöneberg, Torsten BMC Biotechnol Research Article BACKGROUND: Controlling enzyme activity by ligand binding to a regulatory domain of choice may have many applications e.g. as biosensors and as tools in regulating cellular functions. However, until now only a small number of ligand-binding domains have been successfully linked to enzyme activity. G protein-coupled receptors (GPCR) are capable of recognizing an extraordinary structural variety of extracellular signals including inorganic and organic molecules. Ligand binding to GPCR results in conformational changes involving the transmembrane helices. Here, we assessed whether ligand-induced conformational changes within the GPCR helix bundle can be utilized to control the activity of an integrated enzyme. RESULTS: As a proof of principle, we inserted the luciferase amino acid sequence into the third intracellular loop of the M(3 )muscarinic acetylcholine receptor. This fusion protein retained both receptor and enzyme function. Receptor blockers slightly but significantly reduced enzyme activity. By successive deletion mutagenesis the enzyme activity was optimally coupled to ligand-induced conformational helix movements. CONCLUSION: Our results demonstrate that in engineered GPCR-enzyme chimeras, intracellular enzyme activity can be directly controlled by a GPCR serving as the extracellular ligand-binding domain. BioMed Central 2009-05-18 /pmc/articles/PMC2689208/ /pubmed/19450256 http://dx.doi.org/10.1186/1472-6750-9-46 Text en Copyright © 2009 Thor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Thor, Doreen
Le Duc, Diana
Strotmann, Rainer
Schöneberg, Torsten
Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title_full Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title_fullStr Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title_full_unstemmed Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title_short Luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
title_sort luciferase activity under direct ligand-dependent control of a muscarinic acetylcholine receptor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689208/
https://www.ncbi.nlm.nih.gov/pubmed/19450256
http://dx.doi.org/10.1186/1472-6750-9-46
work_keys_str_mv AT thordoreen luciferaseactivityunderdirectliganddependentcontrolofamuscarinicacetylcholinereceptor
AT leducdiana luciferaseactivityunderdirectliganddependentcontrolofamuscarinicacetylcholinereceptor
AT strotmannrainer luciferaseactivityunderdirectliganddependentcontrolofamuscarinicacetylcholinereceptor
AT schonebergtorsten luciferaseactivityunderdirectliganddependentcontrolofamuscarinicacetylcholinereceptor